Please find below some recent articles published by us
Our partner Dr Christian Stallberg will speak at the 26. Marburger Gespräche zum Pharmarecht on 17th March on the topic “The SHI Financial Stabilisation Act and its Consequences – Open Questions and Problems from a Legal Perspective”.
Further information can be found here.…
In a nutshell, the Commission´s proposal of a new Product Liability Directive implements rather extensive rules presuming defectiveness of the product and/or the causal link between its defectiveness and the damage for the benefit of the claimants. In addition, disclosure obligations for defendants are implemented to ease the position of …
Düsseldorf. The term “hypoallergenic” is used today for a wide range of consumer products, from plasters to cosmetics to baby food. Now the highest court has ruled: The statement “hypoallergenic” does not mean that a product is completely free of allergenic ingredients. Rather, consumers correctly assume that only fewer of …
Our partner Dr. Christian Stallberg will speak about the topic “Wound care / What applies when and for what” at the online seminar of the BVMed Akademie on 29 March, 2022. There he will present on the legal basis, current implementation issues and the reporting obligations of manufacturers in the …
Our partner Dr. Marc Oeben holds the lecture “National Pharmaceutical Liability Law III – Practical Implementation and International Pharmaceutical Liability Law” as part of the additional qualification in pharmaceutical law at the Philipps University of Marburg. With the additional qualification in pharmaceutical law, the Faculty of Law at the Philipps …
Düsseldorf, 9 March 2021 – NOVACOS has advised investment firm Triton Fund V alongside De Brauw Blackstone Westbroek on an agreement to invest in Bergman Clinics, one of the leading chains of independent clinics in the Netherlands, Germany and Scandinavia. This investment will be in partnership with the current shareholders …